Emrelis 00074-1055-01
Generic: Telisotuzumab Vedotin
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 14, 2025
- Listing Expires
- December 31, 2026
- Application
- BLA761384
Need to source Emrelis? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Telisotuzumab Vedotin | 100 mg/mL |
Selected Package
00074-1055-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1055-01) / 1 mL in 1 VIAL, SINGLE-DOSE